Monday, Sept. 8

7:00 a.m.- 8:15 a.m.

Clinical Pharmacology and Drug-Drug Interactions of Direct Acting Antivirals (DAA) for Hepatitis C
Update on Antimicrobial Resistance and Implications on Control Strategies for Staphylococcal and Enterococcal Infection or Colonization
PANDAs: Yes or No
Resistance to HIV Integrase and CCR5 Inhibitors
Top Papers of the Year in Infection Prevention and Hospital Epidemiology
Clinical Trials Networks in Non-HIV Infectious Diseases
The Power of Genomic Fungal Sequencing: What Does It Mean for Evolution and Pathobiology? How Do We Use It in Clinics?
Novel Chemotherapy for Helminthes, Especially Filariasis
What Defines Donor Safety in Solid Organ Transplantation
Antiviral Drug Resistance for Cytomegalovirus and Influenza


8:30 a.m. - 10:30 a.m.
Interactive Symposia

Cases in Clinical Microbiology
Current Clinical Issues in HIV Disease Management: An IAS-USA Interactive, Case-Based Session


Clinical Pharmacology and Anti-Infective Drug Development for Pediatric Patients
MERS Coronavirus as a Model for Emerging Pathogen Discovery
Cutting Edge Information on Antibiotic Resistance from the Next Generation of Investigators
Alternative Treatment Approaches for Bacterial Infections
Hot Topics in Vaccines
Expanding the Focus of Antimicrobial Stewardship: Moving Beyond Cost and Utilization As Measures of Success
Food and Water and Their Relationship to Community-Acquired Infections
Noroviruses in the 21st Century: What Have We Learned? Where Are We Going?


8:30 a.m. - 11:00 a.m.
Slide Sessions

Basic Mechanisms in Fungal Pathogenesis and Resistance
Neglected Tropical Diseases, Parasitic Helminthic and Protozoan Infections, Malaria, Global Health, and Travel Medicine
New Insights into Emergence and Function of Beta-Lactamases
The Trouble with Bacteria: A Transplant Perspective
Respiratory Viruses: Treatment Challenges and Viral Kinetics


11:00 a.m. - 1:00 p.m.
Poster Sessions

Clinical Pharmacology and Therapeutic Drug Monitoring of Vancomycin and Newer Lipoglycopeptides/Lipopeptides
Pharmacokinetics/Pharmacodynamics of Beta-Lactams and Beta-Lactamase Inhibitors
Gram-Positive Organisms, Mycobacteria, and Eukaryotes
Aminoglycosides and Newer Gram Negative Agents: Recent Insights
Linezolid, Vancomycin, and Other Resistances in Gram-Positives
Mycobacteria and Neisseria, the Re-Emerging Threats
New Issues on Biofilm-Producing Organisms
New Mechanisms of Action in Antibacterial Agents
Quinolone Resistance: Chromosomal and Plasmid Determinants
The Interplaying Mechanisms Leading to Multidrug Resistance
Update on Clinical and Epidemiological Issues Related to Streptococcus pneumoniae
Worldwide Dissemination of Multidrug-Resistant Acinetobacter spp.
Novel Methods and Algorithms for Pathogen Detection in Various Sample Types
Pathogen Detection and Identification by Mass Spectrometry
Resistance Detection and Strain Characterization Using Mass Spectrometry
Advances Against Gram-Negative Pathogens
Beta-Lactam-Siderophore Conjugates: Trojan Horse Antibiotics
Miscellaneous Agents Including Antiviral and Antiparasitic Agents
New Antifungal Agents on the Horizon
New Spins on Protein Synthesis Inhibitors
Therapies for Mycobacteria Infections
HIV Pathogenesis, Co-Morbidities and Complications
Bloodstream Infections
Bone and Joint Infections
Outbreaks, Other Infection Prevention Issues, and Other Infections
Respiratory Colonization and Infection Respiratory Tract Colonization and Infection
Skin and Soft Tissue Infections
Surgical Site Infections Including Infected Implants
The Environment and Infection Prevention
Urinary Tract Infections including Catheter-Associated Urinary Tract Infections
Clinical Studies in Skin and Skin Structure Infections
Clinical Studies of Endocarditis
Clinical Studies of Pneumonia and Oher Respiratory Tract Infections
Clinical Mycology
Infectious Challenges in Compromised Patients: Bacterial Agents and Related Issues
Respiratory and Other Viruses: Novel Treatments, Resistance, and Clinical Observations


1:30 p.m. - 2:30 p.m.
Special Address


3:00 p.m. - 5:00 p.m.
Interactive Symposia

Pharmacokinetic/Pharmacodynamic Considerations of Anti-Infective Agents in Critically Ill Patients
New Frontiers in the Management of Infections in Transplant Recipients


Idiopathic CD4 Lymphocytopenia: 20 Years Later
Aminoglycoside Resistance in Gram-Negative Bacteria
Antimicrobial Susceptibility Testing Update—2014
Progress on the Ribosome
Systems Biological Approaches to Understanding Immunity to Vaccination and Infections in Humans
Transmission of Viral Pathogens In the Healthcare Setting
Conundrums in Tuberculosis
Special Populations Requiring Special Considerations


3:00 p.m. - 5:30 p.m.
Slide Sessions

Clostridum difficile: Pathogenesis, Immune Response, and Therapy
Clinical and Molecular Epidemiology of Carbapenemase-Producing Enterobacteriaceae
Fungal Infections and Pharmacology
Epidemiology and Treatment of Staphylococcus aureus Infections
New Clinical Data on Pneumonia
Progress in the Management of Severe Infections